期刊文献+

北京地区35~64岁农村妇女高危型HPV感染情况分析 被引量:16

Analysis of high-risk type HPV infection in 35 to 64 years old rural women in Beijing
原文传递
导出
摘要 目的通过采用高危型人乳头瘤病毒(HPV)作为宫颈癌初筛方法,了解北京地区35~64岁农村妇女高危型HPV感染现状及高危型HPV作为初筛的效果。方法回顾性分析2014年10月至2015年3月北京市5个农村两癌筛查区县,年龄35~64岁农村户籍人口20 076名,以高危型HPV作为初筛进行宫颈癌筛查试点的结果,使用SPSS17.0软件对数据进行描述性分析。结果北京地区35~64岁20 076名农村妇女中,高危型HPV总感染率为7.6%(1 535/20 076),其中单一感染排前五位的高危亚型分别是HPV16型219例,占14.3%,HPV52型146例,占9.5%,HPV58型101例,占6.6%,HPV18型84例,占5.5%,HPV51型66例,占4.3%。高危型HPV混合感染率为7.6%(116/1 535),最多同时感染四种高危亚型。35~40岁、41~45岁、46~50岁、51~55岁、56~60岁、61~64岁高危型HPV检测率分别为50.0%(192/384)、38.9%(330/848)、33.0%(388/1 177)、6.3%(298/4 757)、3.4%(251/7 438)和1.4%(76/5 472)。除高危型HPV16/18感染者外,其他型感染者细胞学阳性检出率为13.0%(154/1 188);转诊阴道镜检查率为2.3%(461/20 076);阴道镜下活检组织病理学检出CIN2 27例,CIN3 39例,宫颈微小浸润癌2例,浸润癌1例,癌及癌前病变检出率为343.7/10万,宫颈癌检出率为14.9/10万,早诊率为98.6%(68/69);在宫颈高级别病变及癌中,HPV16/18亚型感染占71.0%(49/69)。结论 HPV16、52和58型是北京地区35~64岁农村妇女单一感染的主要基因亚型,高危型HPV检出率最高为35~40岁,HPV16/18感染是导致宫颈高级别病变及癌的主要亚型。用高危型HPV作为初筛方法,初筛阳性病历检出率提高,而且用高危型HPV分流后,细胞学的工作量明显减少。 Objective Usinghigh-risk HPV test as primary cervical cancer screening, to detect the situation of high-risk HPV infection in 35 to 64 years old women inruralareas of Beijingand the effect of this methodology. Methods Data of 20 076 women among 35 - 64 years lived in in five rural areasof Beijing including Haidian District, Changping District, Shunyi District, Tongzhou District and Miyun County under went cervial cancer screening by using high-risk HPV test as primary screening in 2014. Results Total high-risk HPV infection rate was 7.6% of the 20 076 cases, of which the top five high-risk subtypes of single infectioni case was HPV16 (219/20 076, 14.3%), HPV52 ( 146/20 076, 9.5%), HPV58 (101/20 076, 6.9%), HPV18 (84/20 076, 5.5%), and HPV51 (66/20 076, 4.3%). Co-infection rate of high- risk HPV infection was 7.6% ( 116/20 076), the most serious infection was four types of high-risk HPV subtypes are detected in one woman. High-risk HPV infection rates of 35 - 40 years old, 41 - 45 years old, 46 - 50 years old, 51 - 55 years old, 56- 60 years old, and61- 64 years old were 50.0 % (192/384), 38.9% (330/848), 33.0% (388/1 177), 6.3% (298/4 757), 3.4% (251/7 438) and 1.4% (76/5 472), respectively.In addition, cytology positive rate was 13.0% among high-risk HPV infections except HPV16/18. 461 cases accepted colposcopy, which was 2.3%~ among these, CIN2 was 27cases, CIN3 was 39 cases, microinvasive carcinoma was 2 cases, and 1 case of invasive cancer. Detection rate of precancerous lesion was 343.7/100 000 and detection rate of cervical cancer was 14.9/100 000, early diagnosis rate of cervical cancer was 98.6%. For HSIL and cervical cancers, HPV16/18 subtype infection accounted for 71.0%. Conclusion Major high-risk HPV infection of 35 - 64 years old women in rural Beijing was HPV16, 52 and 58. The highest high-risk HPV detection rate was found among 35 - 40 years old women, HPV16/18 infections are major cause of HSIL and cervical cancer. Started with high-risk HPV detection cervical cancer screening, detection rate of screening positive results has increased while significantly reducing the workload of cytologists.
出处 《中国妇产科临床杂志》 CSCD 北大核心 2015年第6期494-497,共4页 Chinese Journal of Clinical Obstetrics and Gynecology
基金 2014年国家自然科学基金(71373166)
关键词 人乳头瘤病毒 宫颈癌 宫颈上皮内瘤变 宫颈癌筛查 human papilloma virus cervical cancer cervical intraepithelial neoplasia cervical cancer screening
  • 相关文献

参考文献13

  • 1WHO. WHO guidelines for screening and treatment of precancerous lesions for cervical cancer prevention. World Health Organization, 2013 [EB/OL]. [2015-09-01]. http . /Iwww.who.inlJreproductivehealthlpublicationslcancers! screening_and_treatment_of_precancerous_lesions/en/.
  • 2Cox JT. Human papillomavirus testing in primary cervical screening and abnormal papanicolaou management. Obstet GynecolSurv, 2006, 61: S15-25.
  • 3Wang R, Guo X, Wisman GBA, et al.Nationwide prevalence of human papillomavirus infection and viral genotype distribution in 37 cities in China. BMC Infect Dis, 2015, 15. 257-267.
  • 4赵娜,赵方辉,高晓虹,等.城市和农村妇女高危型人乳头瘤病毒感染的危险因素分析[J].中华肿瘤防治杂志,2011,18(16):1225-1229.
  • 5de Sanjose S, Diaz M, Castellsague X, et al.Worldwide prevalence and genotype distribution of cervical human papillomavirus DNA in women with normal cytology: a meta- analysis. Lancet Infect Dis, 2007, 7: 453-459.
  • 6冯金鸽,陈新,朱芸,刘子莲,孙瑞凤,朱威.北京地区女性宫颈感染人乳头瘤病毒基因型分布特征研究[J].实用皮肤病学杂志,2014,7(2):81-84. 被引量:26
  • 7李霓,代敏.中国妇女人乳头状瘤病毒感染的多中心横断面研究[J].中华疾病控制杂志,2008,12(5):411-415. 被引量:97
  • 8应倩,夏庆民,郑荣寿,张思维,陈万青.中国2009年宫颈癌发病与死亡分析[J].中国肿瘤,2013,22(8):612-616. 被引量:156
  • 9Wright TC Jr, Stoler MH, Sharma A, et al. Evaluation of HPV-16 and HPV-18 genotyping for the triage of women with high-risk HPV+cytology-negative results. Am J Clin Pathol, 2011, 136: 578-586.
  • 10Ciapponi A, Bardach A, Glujovsky D, et al. The type-specific HPV prevalence in cervical cancer and high-grade lesions in Latin America and the Caribbean: systematic review and meta- analysis.PLoSOne, 2011, 6: e25493.

二级参考文献44

  • 1李霓,马聪萍,孙立新,张永贞,张永贞,邢菊霞,邵淑丽,邢菊霞,鲍彦平,黄瑞德,贺立绩,乔友林.碘染色肉眼观察作为宫颈癌初筛方法的效果评价[J].中华流行病学杂志,2006,27(1):15-18. 被引量:38
  • 2全国肿瘤登记中心.中国肿瘤登记工作指导手册[M].北京:中国协和医科大学出版社,2004.48-50.
  • 3Ferlay J, Shin HR, Bray F, et al. Cancer incidence and mortalityworldwide : IARC Cancer Base No. 10. http://globocan.iarc.fr/.2010. GLOBOCAN 2008 v2.0.
  • 4Bray F, Ren JS,Masuyer E,et al. Estimates of global cancerprevalence for 27 sites in the adult population in 2008. Int JCancer ,2012 [ Epub ahead of print ].
  • 5Society AC. What are the key statistics about cervical cancer?http : //web.archive.org/web/20071030194439/http : //www.cancer.org/docroot/CRI/content/CRI_2_ 1 X_What_are_the_key_4_statistics_for_cervical_cancer_8.asp? sitearea=. 2006.
  • 6Zhou XH,Obuchowski NA,McClish DK. Statistical Methods inDiagnostic Medicine(诊断医学统计学).宇传华,译.北京:人民卫生出版社,2005.
  • 7Leisenring W, Alonzo T, Pepe MS. Comparisons of predictivevalues of binary medical diagnostic tests for paired designs.Biometrics,2000,56(2):345-351.
  • 8Wang W, Davis CS, Soong SJ. Comparison of predictive valuesof two diagnostic tests from the same sample of subjects usingweighted least squares. Stat Med,2006,25( 13) :2215-2229.
  • 9Nofuentes JAR, Castillo JD, Alonso MAM. Global hypothesistest to simultaneously compare the predictive values of twobinary diagnostic tests. Comput Stat Data Anal, 2012, 56 (5):1161- 1173.
  • 10Grizzle JE, Starmer CF, Koch GG. Analysis of categorical databy linear models. Biometrics,1969,25(3) :489-504.

共引文献325

同被引文献136

引证文献16

二级引证文献68

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部